406 related articles for article (PubMed ID: 23583003)
1. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
2. D-penicillamine treatment of copper-associated hepatitis in Labrador retrievers.
Fieten H; Dirksen K; van den Ingh TS; Winter EA; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Jun; 196(3):522-7. PubMed ID: 23375251
[TBL] [Abstract][Full Text] [Related]
3. Nutritional management of inherited copper-associated hepatitis in the Labrador retriever.
Fieten H; Biourge VC; Watson AL; Leegwater PA; van den Ingh TS; Rothuizen J
Vet J; 2014 Mar; 199(3):429-33. PubMed ID: 24439471
[TBL] [Abstract][Full Text] [Related]
4. Canine Copper-Associated Hepatitis.
Dirksen K; Fieten H
Vet Clin North Am Small Anim Pract; 2017 May; 47(3):631-644. PubMed ID: 28063745
[TBL] [Abstract][Full Text] [Related]
5. Urinary copper excretion and hepatic copper concentrations in liver disease.
Frommer DJ
Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
[TBL] [Abstract][Full Text] [Related]
6. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
Walshe JM
QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
[TBL] [Abstract][Full Text] [Related]
7. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers.
Twedt DC; Hunsaker HA; Allen KG
J Am Vet Med Assoc; 1988 Jan; 192(1):52-6. PubMed ID: 3343179
[TBL] [Abstract][Full Text] [Related]
8. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
[TBL] [Abstract][Full Text] [Related]
9. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
10. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
11. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of COMMD1 in copper toxicosis in Labrador retrievers and Dobermans.
Wu X; Mandigers PJJ; Fieten H; Leegwater PA
Vet J; 2020 Nov; 265():105561. PubMed ID: 33129558
[TBL] [Abstract][Full Text] [Related]
13. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
Marecek Z; Heyrovský A; Volek V
Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
[TBL] [Abstract][Full Text] [Related]
14. Practical recommendations and new therapies for Wilson's disease.
Brewer GJ
Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
[TBL] [Abstract][Full Text] [Related]
16. Association of dietary copper and zinc levels with hepatic copper and zinc concentration in Labrador Retrievers.
Fieten H; Hooijer-Nouwens BD; Biourge VC; Leegwater PA; Watson AL; van den Ingh TS; Rothuizen J
J Vet Intern Med; 2012; 26(6):1274-80. PubMed ID: 22998127
[TBL] [Abstract][Full Text] [Related]
17. A clinical study of Wilson's disease: The experience of a single Egyptian Paediatric Hepatology Unit.
El-Karaksy H; Fahmy M; El-Raziky MS; El-Hawary M; El-Sayed R; El-Koofy N; El-Mougy F; El-Hennawy A; El-Shabrawi M
Arab J Gastroenterol; 2011 Sep; 12(3):125-30. PubMed ID: 22055589
[TBL] [Abstract][Full Text] [Related]
18. Inherited, chronic, progressive hepatic degeneration in Bedlington terriers with increased liver copper concentrations: clinical and pathologic observations and comparison with other copper-associated liver diseases.
Hultgren BD; Stevens JB; Hardy RM
Am J Vet Res; 1986 Feb; 47(2):365-77. PubMed ID: 3954222
[TBL] [Abstract][Full Text] [Related]
19. Hepatic copper concentrations in Labrador Retrievers with and without chronic hepatitis: 72 cases (1980-2010).
Johnston AN; Center SA; McDonough SP; Wakshlag JJ; Warner KL
J Am Vet Med Assoc; 2013 Feb; 242(3):372-80. PubMed ID: 23327181
[TBL] [Abstract][Full Text] [Related]
20. Trace metal interactions in vivo: inorganic cobalt enhances urinary copper excretion without producing an associated zincuresis in rats.
Rosenberg DW; Kappas A
J Nutr; 1989 Sep; 119(9):1259-68. PubMed ID: 2795240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
